Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc. > Third quarter results
View:
Post by RazeKreations on Aug 05, 2022 11:54am

Third quarter results

Next week will be 3rd quarter earnings report and the following week August 17th there will be a webinar with Adelaide Capital and Cameron Groome discussing those results and there should be some forward looking information n how the 4th quarter is proceeding. Should be very interesting when the fouth quarter is released in December. It will be the fourth quarter that will show the benefits of the upgrades and expansion's. Third quarter was too early to benefit from those upgrades. It will be interesting
Comment by wizzdumb on Aug 05, 2022 12:11pm
The Adelaide webinar will be fun. Third quarter will be good but likely nothing exciting. It's all about their tone on how the fourth quarter is shaping up since no formal releases at all on new contracts signed or anything else other than conferences. I am hopeful we won't hear any signs of backtracking on all the previous hype. If the they pull another stunt like they did with Kinlytic a ...more  
Comment by ssdasmm on Aug 05, 2022 1:39pm
Can't wait for the update, we will get a look through the crystal ball and see what the future holds for MBX.  GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities